Evaluating the Impact of Multi‐Institutional Care in Early‐Stage Hepatocellular Carcinoma: A Nationwide Analysis
World Journal of Surgery · 2025-07 · 49 (7) · 1881-1890
DOI: 10.1002/wjs.12635 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, online erschienen am 20.06.2025. Verfasst von Gordana Rasic und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Health Resources Services Administration's National Research Service Award, HRSA HHS.
Abstract (Originalsprache)
Background
Oncologic care received at more than one institution has been shown to negatively impact patient survival in gastric and rectal cancers. Our study evaluated the effect of multi‐institutional care (MC) on time to treatment initiation (TTI) and survival in early‐stage HCC.
Methods
The National Cancer Database was queried for patients with Stage I and II HCC (2004–2020). Patients were categorized as single‐institution care (SC) or multi‐institutional care (MC). A negative binomial regression model was used to identify predictors of increased TTI. Survival analyses were estimated with the Kaplan–Meier method.
Results
Of 12,704 patients, 51% ( n = 6471) received MC and 49% ( n = 6233) SC. MC patients were more often older ( p < 0.0001), White ( p < 0.0001), privately insured ( p < 0.0001), and traveling greater distances ( p = 0.0001). Median TTI was longer for MC patients than SC (61 vs. 50 days; p < 0.0001). Black, underinsured (Medicaid/other government insurance), and MC patients were associated with increased TTI by factors of 1.131 (95% CI: 1.093–1.170; p < 0.0001), 1.081 (95% CI: 1.046–1.119; p < 0.0001), and 1.203 (95% CI: 1.176–1.231; p < 0.0001). Survival was similar between MC and SC at 1 year ( p = 0.1514) and 5 years ( p = 0.1769).
Conclusions
Despite increased treatment time, there was no appreciable survival disadvantage among patients receiving care at multiple sites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
ORCID-Profile: Gordana Rasic
Förderung
- Health Resources Services Administration's National Research Service Award
- HRSA HHS
Zitieren
APA
Rasic, G., Beaulieu-Jone, B. R., Chung, S. H., Romatoski, K. S., Kenzik, K., Ng, S. C., Tseng, J. F., & Sachs, T. E. (2025). Evaluating the Impact of Multi‐Institutional Care in Early‐Stage Hepatocellular Carcinoma: A Nationwide Analysis. World Journal of Surgery, 49(7), 1881-1890. https://doi.org/10.1002/wjs.12635
Vancouver
Rasic G, Beaulieu-Jone BR, Chung SH, Romatoski KS, Kenzik K, Ng SC, et al. Evaluating the Impact of Multi‐Institutional Care in Early‐Stage Hepatocellular Carcinoma: A Nationwide Analysis. World Journal of Surgery. 2025;49(7):1881-1890. doi:10.1002/wjs.12635
BibTeX
@article{Rasic2025,
author = {Rasic, Gordana and Beaulieu-Jone, Brendin R and Chung, Sophie H and Romatoski, Kelsey S and Kenzik, Kelly and Ng, Sing Chau and Tseng, Jennifer F and Sachs, Teviah E},
title = {Evaluating the Impact of Multi‐Institutional Care in Early‐Stage Hepatocellular Carcinoma: A Nationwide Analysis},
journal = {World Journal of Surgery},
year = {2025},
volume = {49},
number = {7},
pages = {1881--1890},
doi = {10.1002/wjs.12635}
}
EUVIMED